http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007140181-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_496659645a2523bbf1bb657f66c87654 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e911305f2cb02b43368a069a93d30519 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate | 2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586f1bf7b97515a653bdb71428c97fa3 |
| publicationDate | 2008-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2007140181-A3 |
| titleOfInvention | Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine receptor antagonist |
| abstract | The present invention relates to a pharmaceutical combination comprising an adenosine uptake inhibitor, or a pharmaceutically acceptable salt thereof, and a non-selective adenosine receptor antagonist, or a pharmaceutically acceptable salt thereof, for the treatment of cancer diseases, and inflammatory disorders such as rheumatoid arthritis, osteoarthritis, psoriasis and dry eye syndrome, through stimulation of the adenosine A3 receptor. |
| priorityDate | 2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.